Transcend Capital Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,372	Closed	-$238K	–	606
2024 Q3	$238K	Sell	3,372 -1	-0%	-$70	0.02%	532
2024 Q2	$224K	Buy	3,373 +1	+0%	+$66	0.02%	529
2024 Q1	$229K	Hold	3,372	–	–	0.02%	475
2023 Q4	$208K	Buy	+3,372	New	+$198K	0.02%	463
2023 Q3	–	Sell	-3,372	Closed	-$201K	–	503
2023 Q2	$201K	Buy	+3,372	New	+$200K	0.02%	455
2023 Q1	–	Sell	-3,372	Closed	-$209K	–	506
2022 Q4	$209K	Buy	+3,372	New	+$203K	0.02%	441
2022 Q3	–	Sell	-3,372	Closed	-$215K	–	502
2022 Q2	$215K	Buy	3,372 +45	+1%	+$2.86K	0.02%	442
2022 Q1	$215K	Hold	3,327	–	–	0.02%	462
2021 Q4	$221K	Hold	3,327	–	–	0.02%	438
2021 Q3	$208K	Hold	3,327	–	–	0.02%	451
2021 Q2	$206K	Buy	+3,327	New	+$202K	0.03%	305